Literature DB >> 26515629

Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Richard S Bedlack1, Nanette Joyce2, Gregory T Carter3, Sabrina Paganoni4, Chafic Karam5.   

Abstract

Given the severity of their illness and lack of effective disease-modifying agents, it is not surprising that most patients with amyotrophic lateral sclerosis (ALS) consider trying complementary and alternative therapies. Some of the most commonly considered alternative therapies include special diets, nutritional supplements, cannabis, acupuncture, chelation, and energy healing. This article reviews these in detail. The authors also describe 3 models by which physicians may frame discussions about alternative therapies: paternalism, autonomy, and shared decision making. Finally, the authors review a program called ALSUntangled, which uses shared decision making to review alternative therapies for ALS.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autonomy; Complementary and alternative medicine; Paternalism

Mesh:

Year:  2015        PMID: 26515629      PMCID: PMC4712627          DOI: 10.1016/j.ncl.2015.07.008

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  188 in total

1.  Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity.

Authors:  M E Abood; G Rizvi; N Sallapudi; S D McAllister
Journal:  Neurosci Lett       Date:  2001-08-31       Impact factor: 3.046

Review 2.  Medicinal cannabis: rational guidelines for dosing.

Authors:  Gregory T Carter; Patrick Weydt; Muraco Kyashna-Tocha; Donald I Abrams
Journal:  IDrugs       Date:  2004-05

3.  High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study.

Authors:  Johannes Dorst; Joschka Cypionka; Albert C Ludolph
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-08-14       Impact factor: 4.092

4.  Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study.

Authors:  Johannes Dorst; Luc Dupuis; Susanne Petri; Katja Kollewe; Susanne Abdulla; Joachim Wolf; Markus Weber; David Czell; Christian Burkhardt; Frank Hanisch; Stefan Vielhaber; Thomas Meyer; Gabriele Frisch; Dagmar Kettemann; Torsten Grehl; Bertold Schrank; Albert C Ludolph
Journal:  J Neurol       Date:  2015-01-25       Impact factor: 4.849

Review 5.  Marijuana in the management of amyotrophic lateral sclerosis.

Authors:  G T Carter; B S Rosen
Journal:  Am J Hosp Palliat Care       Date:  2001 Jul-Aug       Impact factor: 2.500

Review 6.  Creatine for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  Daniel M Pastula; Dan H Moore; Richard S Bedlack
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

7.  Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis.

Authors:  Edward J Kasarskis; Marta S Mendiondo; Dwight E Matthews; Hiroshi Mitsumoto; Rup Tandan; Zachary Simmons; Mark B Bromberg; Richard J Kryscio
Journal:  Am J Clin Nutr       Date:  2014-02-12       Impact factor: 7.045

8.  Patient reports of adverse events associated with acupuncture treatment: a prospective national survey.

Authors:  H Macpherson; A Scullion; K J Thomas; S Walters
Journal:  Qual Saf Health Care       Date:  2004-10

Review 9.  Acupuncture for spasticity after stroke: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Sung Min Lim; Junghee Yoo; Euiju Lee; Hyun Jung Kim; Seungwon Shin; Gajin Han; Hyeong Sik Ahn
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-05       Impact factor: 2.629

10.  Vitamin D(3) at 50x AI attenuates the decline in paw grip endurance, but not disease outcomes, in the G93A mouse model of ALS, and is toxic in females.

Authors:  Alexandro Gianforcaro; Jesse A Solomon; Mazen J Hamadeh
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more
  10 in total

1.  Toenail mercury Levels are associated with amyotrophic lateral sclerosis risk.

Authors:  Angeline S Andrew; Celia Y Chen; Tracie A Caller; Rup Tandan; Patricia L Henegan; Brian P Jackson; Brenda P Hall; Walter G Bradley; Elijah W Stommel
Journal:  Muscle Nerve       Date:  2018-01-04       Impact factor: 3.217

2.  Dihuang Yinzi, a Classical Chinese Herbal Prescription, for Amyotrophic Lateral Sclerosis: A 12-Year Follow-up Case Report.

Authors:  Hui Qiu; Ji-Huang Li; Su-Bing Yin; Jiang-Qiong Ke; Chang-Lin Qiu; Guo-Qing Zheng
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

Review 3.  Therapeutic opportunities and challenges of induced pluripotent stem cells-derived motor neurons for treatment of amyotrophic lateral sclerosis and motor neuron disease.

Authors:  Manoj Kumar Jaiswal
Journal:  Neural Regen Res       Date:  2017-05       Impact factor: 5.135

4.  Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial.

Authors:  Sungha Kim; Jae Kyoun Kim; Mi Ju Son; Dongwoung Kim; Bongkeun Song; Ilhong Son; Hyung Won Kang; Jongdeok Lee; Sungchul Kim
Journal:  Trials       Date:  2018-04-13       Impact factor: 2.279

5.  Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea.

Authors:  Sungha Kim; Sujeong Mun; Jeonghwan Park; Sunmi Choi; Sanghun Lee; Sungchul Kim
Journal:  Evid Based Complement Alternat Med       Date:  2019-07-25       Impact factor: 2.629

6.  Is the evidence strong enough for acupuncture ameliorates clinical symptoms in patients with amyotrophic lateral sclerosis: A protocol for a systematic review and meta-analysis.

Authors:  Qun Liao; Zunjiang Li; Hai Zeng; Xiaocong Feng; Wei Huang; Chuying Fu; Xiaolin Liang; Tian Li
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 7.  A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies.

Authors:  Sibel Suzen; Paolo Tucci; Elisabetta Profumo; Brigitta Buttari; Luciano Saso
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-31

Review 8.  Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?

Authors:  Bradley Roberts; Frances Theunissen; Francis L Mastaglia; P Anthony Akkari; Loren L Flynn
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

9.  Anti-Inflammatory Effect of Gamisoyo-San in an Animal Model of Amyotrophic Lateral Sclerosis.

Authors:  Sunjung Park; Eun Jin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-21       Impact factor: 2.629

Review 10.  Organ on a Chip: A Novel in vitro Biomimetic Strategy in Amyotrophic Lateral Sclerosis (ALS) Modeling.

Authors:  Babak Arjmand; Shayesteh Kokabi Hamidpour; Zahra Rabbani; Akram Tayanloo-Beik; Fakher Rahim; Hamid Reza Aghayan; Bagher Larijani
Journal:  Front Neurol       Date:  2022-01-17       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.